ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News Release and Conference Call Read more about ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News Release and Conference Call
ACETO Subsidiary, Rising Pharmaceuticals, to Launch Fluocinolone Acetonide OTIC Oil, 0.01% Read more about ACETO Subsidiary, Rising Pharmaceuticals, to Launch Fluocinolone Acetonide OTIC Oil, 0.01%
ACETO Appoints William C. Kennally, III to the Board of Directors Read more about ACETO Appoints William C. Kennally, III to the Board of Directors
ACETO to Present at the Morgan Stanley 2016 Global Healthcare Conference Read more about ACETO to Present at the Morgan Stanley 2016 Global Healthcare Conference
ACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results Read more about ACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results
ACETO Board of Directors Increases Quarterly Cash Dividend by 8.3% Read more about ACETO Board of Directors Increases Quarterly Cash Dividend by 8.3%
ACETO Subsidiary, Rising Pharmaceuticals, to launch Fluocinolone Acetonide Body Oil, 0.01%, and Fluocinolone Acetonide Scalp Oil, 0.01% Read more about ACETO Subsidiary, Rising Pharmaceuticals, to launch Fluocinolone Acetonide Body Oil, 0.01%, and Fluocinolone Acetonide Scalp Oil, 0.01%
ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results News Release and Conference Call Read more about ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results News Release and Conference Call
ACETO Names Walter Kaczmarek III Chief Operating Officer Read more about ACETO Names Walter Kaczmarek III Chief Operating Officer
> Investors > 
> Investors >